Today’s recruitment shortages and access to remote research sites pose a challenge in rare disease research — but Cerba means certainty. Together, we can shape and advance your complex trial by leveraging Cerba HealthCare patient databases and biorepositories spanning five continents. AI-driven access to demographically rich data and industry-leading laboratories save you time and effort, enabling your project to move forward.
24%
of our pediatric trials focus on rare diseases
34%
of trials in rare diseases are multiple myeloma trials
12%
of trials in rare diseases are leukemia trials
Acute myeloid leukemia
Acute lymphoblastic leukemia
Chronic lymphocytic leukemia
Enhance your research with patient- and data-driven insights
We offer a broad continuum of services and capabilities for research into rare diseases, particularly cancers. Get the help you need with:
- Custom assay development
- Pediatrics
- Tailored analysis
- Flexible solutions
- AI to find patients
- Genetics / next generation sequencing (NGS)